1) An SK, Lee SJ, Lee Ch, et al:Reduced P3 amplitude by negative facial emotional photographs in schizophrenia. Schizophr Res 64:125-135, 2003
2) Blackwood D:P300, a state and a trait marker in schizophrenia. Lancet 355:771-772, 2000
3) Donchin E, Coles MGH:Is the P300 component a manifestation of context updating? Behavi Brain Sci 11:357, 1988
4) Edwards J, Pattison PE, Jackson HJ, et al:Facial affect and affective prosody recognition in first-episode schizophrenia. Schizophr Res 30:235-153, 2001
5) Herbener ES, Hill SK, Marvin RW, et al:Effects of antipsychotic treatment on emotion perception deficits in first-episode schizophrenia. Am J Psychiatry 162:1746-1748, 2005
6) 稲永和豊,入江伸,浦江明憲,他:塩酸perospirone(SM-9018)の第1相臨床試験.基礎と臨床 31:2113-2157,1997
7) Kay SR, Fiszbein A, Opler LA:The positive and negative syndrome scale(PANSS) for schizophrenia. Schizophr Bull 13:261-276, 1987
8) Lang SF, Nelson CA, Collins PF:Event-related potentials to emotional and neutral stimuli. J Clin Exp Neuropsychol 12:946-958, 1990
9) McCarley RW, Shenton ME, O’Donnell BF, et al:Auditory P300 abnormalities and left posterior superior temporal gyrus volume reduction in schizophrenia. Arch Gen Psychiatry 50:190-197, 1993
10) Molina V, Munoz F, Martin-Loeches M, et al:Long-term olanzapine treatment and P300 parameters in schizophrenia. Neuropsychobiology 50:182-188, 2004
11) 森田喜一郎,早稲田芳史,富田克,他:未服薬統合失調症者と健常者の視覚誘発事象関連電位(P300成分)―情動の影響をふまえて.脳波と筋電図 25:362-368,2002
12) 大野行弘:新規精神分裂病治療薬ペロスピロン(ルーラン)の研究開発.日薬理誌 118:39-42,2001
13) Polich J:Clinical application of the P300 event-related brain potential. Phys Med Rehabil Clin N Am 15:133-161, 2004
14) Prichard WS:Cognitive event-related potential correlates of schizophrenia. Psychol Bull 100:43-66, 1986
15) 山本寛子:未治療統合失調症者の表情弁別課題視覚事象関連電位(P300)と治療後の推移―ペロスピロンとリスペリドンの比較.九州神経精神医学 51:19-28,2005